Sugi Predict

Sugi Predict / Compounds / SCHEMBL18647346

SCHEMBL18647346

SCHEMBL18647346

O=c1[nH]c2ccc3c4ccccc4sc3c2c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 3/20 0.56
▸ TNKS2 Q9H2K2 3/20 0.56
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ HTT P42858 3/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ HCRTR1 O43613 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ PARP1 P09874 7/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GPR3 P46089 2/20 0.44
▸ BLM P54132 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ PARP15 Q460N3 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16919355 0.83 MAPT (0.50) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL29520199 0.82 TNKS (0.57) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL31684 0.82 TNKS (0.57) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL29470199 0.82 TNKS (0.57) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL21564033 0.80 MAPT (0.49) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL18647391 0.79 TNKS (0.54) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL18646713 0.78 TNKS (0.53) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL14951434 0.78 MAPT (0.50) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL18926346 0.78 TNKS (0.55) TNKSTNKS2MEN1KMT2AKDM4E
SCHEMBL18647351 0.78 MEN1 (0.53) TNKSTNKS2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-04-06 — — US disclosed
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-07-16 — — US disclosed
WO-2017043797-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof PIEZO1, OCIAD1, EML4 TNKS 3823/4885TNKS2 4040/4885MEN1 891/4885
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, EML4 TNKS 3823/4885TNKS2 4040/4885MEN1 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.